Clinical Trial Update: Tofogliflozin GLP-1 Analogue Combination Trial [Phase 4]

View source ↗

Summary

Phase 4 trial updating results for tofogliflozin combined with a GLP-1 analogue in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• tofogliflozin

Snippet

Sponsor: Kowa Company, Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED